Market Outlook As it stands right now, the market's poised to close about 2.2% higher for the week. Note, however, that the bulk of the weekly gain was made on Tuesday; we've seen no progress since then. So what? It points to a lack of follow-through, which ultimately suggests the bulls aren't as locked and loaded as they think they are. While volume's been decent on the way up, it hasn't exactly been strong. Of course, the selling volume hasn't been all that strong either.  And the VIX? Yeah, well, it looked like it might have finally made its way into a new uptrend last week (chart below), but no dice. It's back at stunningly-low levels, which should scare the daylight out of the folks who were following the VIX in the late 90's and early 2000's (and to a lesser degree in the mid-2000's). This much persistent confidence rarely turns out to be a good thing. To read the rest of this article, click here. Community Update If you haven't already done so, sign-up to become a member of the SmallCap Network Community. You will be able to comment on articles and create your own space to begin publishing your own content. Stock Picks, Articles, Blogs, Analysis, just to name a few. We are going to being releasing a couple new community functions soon. We're hoping to create more tools that will allowcommunity members to more easily share ideas and thoughts. Be on the lookout...   SCN Community Articles Technical Analysis, Does it Work on Microcap Stocks? Technical analysis is an invaluable tool to most traders. Patterns are repeated over and over again in nature, and the same is true with human emotion. Those emotions are all clearly depicted in the form of a chart, thus causing chart patterns to appear over and over with regularity. For smaller stocks, does the same hold true? Many would argue that all technical analysis breaks down under a certain price threshold. Don Seal takes a look at a couple of small stocks and interprets some technical analysis on them. Radient Pharmaceuticals - Bullish or Bullcrap? M.E. Garza continues to keep the story on Radient Pharmaceuticals going. Garza goes into the details of the company, analyzes other recent material events, and tries to get to the heart of some basic questions regarding the company. Start Profiting From Stocks Approaching Their 52-wk Highs Stocks hitting new highs and new lows can provide significant opportunity for investors. The stocks are about to change directions and go back to the comfortable trading range it has been in, or its about to venture off into waters that are new and unchartered. Take a look at some companies that have hit these thresholds recently and what might be in store for the future. Undervalued: Shares of Momenta Pharmaceuticals Is Momenta Pharmaceuticals undervalued and warrant your attention? "Currently, Momenta Pharmaceuticals (NASDAQ: MNTA) represents an undervalued opportunity with high reward potential and some downside risk. We like the potential going forward in 2011 with updates on their pipeline and Copaxone litigation. Recently, the stock dropped following news from TEVA, that it had received a 'minor deficiency' letter from the FDA regarding questions about TEVA’s ANDA application to sell their generic version of Lovenox." Gold Rush! Prepare for $2000 an Ounce Investors on the gold bandwagon believe that the price of gold still has tremendous room to appreciate before it hits a ceiling. See what companies are available to either begin or diversify your gold investing interests. Historical Short Interest Data Can Help Your Investment Decision Looking at historical data has always been a part of most traders research and due diligence. Trying to find patterns and logic behind price action. What can historical short interest tell us about future price movements of stocks? One website can you important information on short data and help you analyze what it means for that stock. It's Official, Comcast Corporation Takes Over NBC Last Friday the world of media got smaller. After a long courtship, the biggest cable provider in the U.S., Comcast (NASDAQ: CMCSA) took majority control of NBC Universal (now NBCUniversal; one word) from General Electric (NYSE: GE). The deal has been in the works for a long time and the Dept. of Justice and the FCC were as much a part of the transaction as the corporate accountants and boards of directors. More Articles IMAX Corporation Rolls Out Big Time in China and Russia Casino Stocks Reward Investors with Valuation Short Sellers' Bread and Butter Recycled Scrap Metal Bounces Back Cleveland Biolabs (NASDAQ: CBLI) Could See Significant Capital Appreciation Another Short Squeeze Forming At Radient Pharmaceuticals World’s Third Largest Coca Cola Bottler Comes Into Being Again, Biotechnology Investing is Not for the Faint of Heart Stocks Under $5 Showing Increased Activity by Making Headlines Do I See Lipstick On A Pig? Or Is The Stock Market and Gold Still Going Up? Chinese Solar Companies Are Flooding the Market Egypt's Protests Could Favor Shipping Stocks The Drought in Northern China Takes a Toll The Market's Latest 'Value' Based on Earnings, Not That it Matters Right Now TravelCenters of America Doubles Value in a Day NaviSite Merger with Time Warner Raises Questions Electronic Arts Jumps up $3 on Buyback News Diet Pills, the FDA, and Bio-Pharmaceuticals Market Bounces Back, Apparel Booms Sr. Living and Healthcare REIT’s Soar Sunday Banking Remarks from the Prime Minister of Spain Small Cap ETFs, Ever Thought of That? Good and Evil of Agricultural Stocks Four Regional Banks in Growth Mode In a Key Move for Australia, a Rate Stop